RTI Surgical Holdings, Inc.® Appoints Stuart F. Simpson to Board of Directors
May 26 2020 - 4:15PM
RTI Surgical Holdings, Inc. (Nasdaq: RTIX), a global surgical
implant company, today announced the appointment of Stuart F.
Simpson as an independent member of its board of directors.
Mr. Simpson most recently served as the
President of the Joint Replacement Division of Stryker Corporation
(NYSE: SYK), a medical technology company that provides products
and services in orthopedics, medical and surgical, and
neurotechnology and spine (“Stryker”), from 2017 until his
departure from Stryker in 2019. Mr. Simpson held various roles at
Stryker from 1997 until 2019, including VP & General Manager of
the Commercial Business Unit from 2015 until 2017 and VP &
General Manager of the Global Knee & Mako Business Unit from
2014 until 2015. During his tenure at Stryker, Mr. Simpson led a
transformative strategy to establish robotics as a standard of care
for orthopedics industry, led efforts in new product development,
provided both strategic counsel and financial discipline to the
organization. Mr. Simpson also helped Stryker complete three
significant business development transactions, including one with a
publicly traded company. Prior to joining Stryker, Mr. Simpson
gained diverse experience in sales and marketing in the
pharmaceutical and medical technology industry. Mr. Simpson
currently serves as a director of Breg Inc., a provider of
orthopedic and sports medicine products and services.
“Stuart has extensive industry expertise,
particularly in orthopedics and digital strategy, an area that we
believe will be important to our ongoing strategy of new product
development, channel effectiveness and acquisitions,” said Camille
I. Farhat, the Chief Executive Officer of RTI. “We are enthusiastic
about his addition to our Board and believe he will make important
contributions as we progress on our ongoing strategy.”
“I am excited to be joining RTI’s board of
directors and leveraging my industry experience to help RTI further
strengthen its spine business strategy in new ways that drive
growth for the future,” stated Mr. Simpson.
About RTI Surgical Holdings,
Inc.
RTI Surgical Holdings is a leading global
surgical implant company providing surgeons with safe biologic,
metal and synthetic implants. Committed to delivering a higher
standard, RTI’s implants are used in sports medicine, plastic
surgery, spine, orthopedic and trauma procedures and are
distributed in over 50 countries. RTI has four manufacturing
facilities throughout the U.S. and Europe. RTI is accredited in the
U.S. by the American Association of Tissue Banks and is a member of
AdvaMed. For more information, please visit www.rtix.com. Connect
with us on LinkedIn and Twitter.
Forward-Looking Statements
Portions of this document may constitute “forward-looking
statements” as defined by federal law. Although the company
believes any such statements are based on reasonable assumptions,
there is no assurance that actual outcomes will not be materially
different. Any such statements are made in reliance on the “safe
harbor” protections provided under the Private Securities Reform
Act of 1995. Additional information about issues that could lead to
material changes in performance is contained in the company’s
annual and quarterly reports filed with the Securities and Exchange
Commission.
Jonathon Singer Investor and Media Contact jsinger@rtix.com +1
877-343-6832
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From Apr 2024 to May 2024
RTI Surgical (NASDAQ:RTIX)
Historical Stock Chart
From May 2023 to May 2024